Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

NOD2 anticorps (AA 460-733)

NOD2 Reactivité: Humain ELISA, IHC, IF Hôte: Lapin Polyclonal unconjugated
N° du produit ABIN7162073
  • Antigène Voir toutes NOD2 Anticorps
    NOD2 (Nucleotide-Binding Oligomerization Domain Containing 2 (NOD2))
    Épitope
    • 16
    • 5
    • 4
    • 4
    • 3
    • 2
    • 1
    • 1
    AA 460-733
    Reactivité
    • 38
    • 5
    • 4
    Humain
    Hôte
    • 37
    • 3
    • 1
    Lapin
    Clonalité
    • 39
    • 2
    Polyclonal
    Conjugué
    • 20
    • 4
    • 3
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    Cet anticorp NOD2 est non-conjugé
    Application
    • 36
    • 16
    • 14
    • 7
    • 7
    • 6
    • 6
    • 4
    • 2
    • 2
    ELISA, Immunohistochemistry (IHC), Immunofluorescence (IF)
     Réactivité croisée
    Humain
    Purification
    >95%, Protein G purified
    Immunogène
    Recombinant Human Nucleotide-binding oligomerization domain-containing protein 2 protein (460-733AA)
    Isotype
    IgG
    Top Product
    Discover our top product NOD2 Anticorps primaire
  • Indications d'application
    Recommended dilution: IHC:1:20-1:200, IF:1:50-1:200,
    Restrictions
    For Research Use only
  • Format
    Liquid
    Buffer
    Preservative: 0.03 % Proclin 300
    Constituents: 50 % Glycerol, 0.01M PBS, pH 7.4
    Agent conservateur
    ProClin
    Précaution d'utilisation
    This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
    Stock
    -20 °C,-80 °C
    Stockage commentaire
    Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
  • Antigène
    NOD2 (Nucleotide-Binding Oligomerization Domain Containing 2 (NOD2))
    Autre désignation
    NOD2 (NOD2 Produits)
    Synonymes
    anticorps ACUG, anticorps BLAU, anticorps CARD15, anticorps CD, anticorps CLR16.3, anticorps IBD1, anticorps NLRC2, anticorps NOD2B, anticorps PSORAS1, anticorps Card15, anticorps F830032C23Rik, anticorps Nlrc2, anticorps caspase recruitment domain 15 protein, anticorps nucleotide binding oligomerization domain containing 2, anticorps nucleotide-binding oligomerization domain containing 2, anticorps TTHERM_01951320, anticorps NOD2, anticorps Nod2
    Sujet

    Background: Involved in gastrointestinal immunity. Upon stimulation by muramyl dipeptide (MDP), a fragment of bacterial peptidoglycan, binds the proximal adapter receptor-interacting RIPK2, which recruits ubiquitin ligases as XIAP, BIRC2, BIRC3 and the LUBAC complex, triggering activation of MAP kinases and activation of NF-kappa-B signaling. This in turn leads to the transcriptional activation of hundreds of genes involved in immune response. Required for MDP-induced NLRP1-dependent CASP1 activation and IL1B release in macrophages (PubMed:18511561).

    Aliases: ACUG antibody, Arthrocutaneouveal granulomatosis antibody, BLAU antibody, CARD15 antibody, Caspase recruitment domain family, member 15 antibody, Caspase recruitment domain protein 15 antibody, Caspase recruitment domain-containing protein 15 antibody, CD antibody, CLR16.3 antibody, IBD1 antibody, Inflammatory bowel disease protein 1 antibody, LRR containing protein antibody, NLR family, CARD domain containing 2 antibody, NLRC2 antibody, NOD like receptor C2 antibody, NOD2 antibody, NOD2 protein antibody, NOD2_HUMAN antibody, NOD2B antibody, nucleotide binding oligomerization domain 2 antibody, Nucleotide binding oligomerization domain containing 2 antibody, Nucleotide binding oligomerization domain, leucine rich repeat and CARD domain containing 2 antibody, Nucleotide-binding oligomerization domain-containing protein 2 antibody, PSORAS1 antibody

    UniProt
    Q9HC29
    Pathways
    Activation of Innate immune Response, Cellular Response to Molecule of Bacterial Origin, Regulation of Leukocyte Mediated Immunity, Positive Regulation of Immune Effector Process, Production of Molecular Mediator of Immune Response, Toll-Like Receptors Cascades, Inflammasome
Vous êtes ici: